about
Targeted drugs in small-cell lung cancerOrigins, genetic landscape, and emerging therapies of small cell lung cancerActivation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung CancerCheckpoint inhibitors in lung cancer: latest developments and clinical potentialDynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer.Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients.The challenge of using biomarkers and molecularly targeted drugs to improve cure rate in early stage non-small cell lung cancerThe action and mechanism of myrislignan on A549 cells in vitro and in vivo.Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells.The Highest Metabolic Activity on FDG PET Is Associated With Overall Survival in Limited-Stage Small-Cell Lung CancerRRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum DoubletsSmall Cell Lung Cancer: Can Recent Advances in Biology and Molecular Biology Be Translated into Improved Outcomes?GPR171 expression enhances proliferation and metastasis of lung cancer cells.CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients.FAIM2, as a novel diagnostic maker and a potential therapeutic target for small-cell lung cancer and atypical carcinoid.Role of p14ARF and p15INK4B promoter methylation in patients with lung cancer: a systematic meta-analysis.YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.Research progress in the treatment of small cell lung cancer.24-Methyl-Cholesta-5,24(28)-Diene-3β,19-diol-7β-Monoacetate Inhibits Human Small Cell Lung Cancer Growth In Vitro and In Vivo via Apoptosis Induction.Second-line therapy for small cell lung cancer: exploring the potential role of circulating tumor cellsSmoking, inflammation and small cell lung cancer: recent developments.Prognostic value of Ki-67 expression in patients with extensive-stage small cell lung cancer.Small cell lung carcinoma cell line screen of etoposide/carboplatin plus a third agent.Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.Immunotherapy for small-cell lung cancer: emerging evidence.Small cell lung cancer: Recruitment of macrophages by circulating tumor cells.Lung cancer samples preserved in liquid medium: One step beyond cytology.The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.Small cell lung cancer: model of circulating tumor cell tumorospheres in chemoresistance.CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib.Thoracic radiotherapy (TRT) improved survival in both oligo- and polymetastatic extensive stage small cell lung cancer.PD-L1 Expression by Two Complementary Diagnostic Assays and mRNA In Situ Hybridization in Small Cell Lung CancerEmerging strategies for the treatment of advanced small cell lung cancer.A Novel HSP90 Inhibitor-Drug Conjugate to SN38 Is Highly Effective in Small Cell Lung Cancer.Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.Targeting a non-oncogene addiction to the ATR/CHK1 axis for the treatment of small cell lung cancer.Under-treatment of small cell lung cancer: the case for surgical resection.A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinum-refractory small cell lung cancer patients.Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.
P2860
Q26767017-E6117394-2E02-40B1-A590-45946EEDFE02Q26798218-5BD91987-62F9-47D2-9972-48E55F3FD494Q27315948-2DC3517F-3860-4F06-BF36-EDB06085950BQ28076467-2B98DFC9-A839-4B75-9F35-4377F0AE0908Q33709790-7AB8793F-F8CD-48E9-9B6D-7B822D2AA242Q35160337-93B20F4C-986A-4CC9-B2C8-064D64EA2781Q35290441-51BA2269-F618-4EDB-B8B8-1CE427B212F7Q36095323-FD765663-C61F-46C4-8D7C-312B351A9119Q36184617-72E093C2-5442-4C6C-97A1-6A0D52CA3B32Q36567055-A9D4D33C-C413-4824-A625-3F72F009DCCCQ36766225-0F398C0A-BB0A-4355-91C3-E7950F683DB1Q36811784-696C21B0-8C26-4E4B-B2C0-47C10C746B40Q36946647-FDD77F62-9468-4665-8AF4-43127BB5D683Q37042256-22E3F772-E189-4325-A2DD-5FD0F3AB8D3CQ37116260-262CA363-F0F6-4218-9F15-7279DBB0EC93Q37291399-9584684A-7F6B-4430-A7A3-885BA75147F8Q37420737-9D9CEA56-800A-4931-82C7-0AFD4BEA2CCCQ37544346-9C7EBAB8-2D16-4223-9C37-FED6F5AD88AEQ37604301-9E0C2C3C-4AD9-4B73-8C5C-23C96D7289C4Q38369572-47B04F70-6F02-45F2-8C98-2E11A9863B43Q38549648-AAF7F58D-7C0B-4359-9998-7CFE963D76C0Q38569752-279815EF-2FEF-4AB3-A2A4-5B304DA4873BQ38673828-41A83B54-8B3F-4574-839F-8CF0BAF2AD94Q38695896-E4A1BCD8-6510-4D3C-A717-90E4833B3F1AQ38701763-E683F043-69F3-4E86-9EF7-8E3F6A78EB50Q38736126-0198B3F5-7D42-4A49-B050-1F4B4B1298BBQ38773484-3306A3D4-2FD3-41DF-8967-1B3258B9542AQ39356534-44618ECE-10D9-4DDF-8BE9-B204D2147ECDQ39641416-C1B101A2-3D5B-42AA-899E-CECC91057ECFQ41009718-A78902E3-EAC6-47D4-A7EC-C14562E5E9C4Q41466400-4B46B9DD-94DC-495D-B9B0-C9568C0CAC1DQ41504138-54890A78-9B28-4719-8DA1-08E465E69DF8Q41770303-95991C6B-E816-402E-A133-848B5521A66EQ42369314-2BF25847-1ACC-4345-BB0D-89E87DDFDDD0Q42382771-1FDFB9C8-6436-48A1-947F-BFF847F538B2Q47114132-88299B39-D411-4796-899E-0414D80E2F15Q47120183-9384A03D-E6DF-458B-9C76-3A1F099385C4Q47123759-46E3FAAD-AF33-41B1-A123-90F1A96B19FCQ47140337-99D4E745-53DC-45BE-825B-0F72D8E78566Q47140422-A6135F94-7F94-43CE-9C03-8EE21A5EF420
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Small cell lung cancer: where do we go from here?
@ast
Small cell lung cancer: where do we go from here?
@en
type
label
Small cell lung cancer: where do we go from here?
@ast
Small cell lung cancer: where do we go from here?
@en
prefLabel
Small cell lung cancer: where do we go from here?
@ast
Small cell lung cancer: where do we go from here?
@en
P2860
P356
P1433
P1476
Small cell lung cancer: where do we go from here?
@en
P2093
Lauren Averett Byers
P2860
P304
P356
10.1002/CNCR.29098
P407
P577
2014-10-21T00:00:00Z